Zimmer Biomet strikes multiyear orthopedics deal in India

Zimmer Biomet ($ZBH) struck a multiyear deal with India healthcare leaders to bring better orthopedic care to the country.

The Warsaw, IN-based company will work with the Indo UK Institutes of Health (IUIH) to build Biomet Institute of India, a 30,000-square-foot medical training and education facility at a local college hospital. The facility aims to train more than 1,000 orthopedic surgeons a year on new procedures and Zimmer Biomet technology.

Zimmer plans on sinking more than $5 million into the initiative starting in 2017, the company said in a statement. The deal, which will span three years, builds on the company’s presence in the country and addresses a growing need.

Event

Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

“Currently, India has approximately 10 orthopedic surgeons per million people. This is inadequate to meet current demand for orthopedic care, let alone meet the anticipated surge in demand from India's aging population, which is expected to triple by 2030,” Zimmer CEO David Dvorak said in a statement. “Zimmer Biomet's partnership with IUIH addresses this immediate and critical gap in delivering patient care by providing much-needed continuing education and hands-on orthopedic surgical training."

But Zimmer’s contribution is only the tip of the iceberg; Eventually, IUIH and the U.K.’s National Health Service (NHS) want to build 11 training campuses in major states in India. Each campus will include a 1,000-bed hospital, medical and nursing schools and a third party-run training and education center focused on a particular specialty.

- here’s the statement

Related Articles:
Zimmer Biomet enters surgical robotics with Medtech buy
Zimmer Biomet to buy soft tissue reconstruction startup Cayenne Medical
Zimmer Biomet quietly acquires DVT compression startup
Zimmer Biomet is born after knee implant divestiture to S&N
Zimmer, Biomet to join forces in $13.4B deal

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.